Cargando…

Latest Evidence on Sulfonylureas: What’s New?

This review addresses the question of the cardiovascular (CV) safety of sulfonylureas (SUs) in patients with type 2 diabetes mellitus (T2DM) when directly tested against comparator agents in CV outcome trials. Presented at a recent symposium entitled “SUs in the treatment of T2DM: a fresh look and n...

Descripción completa

Detalles Bibliográficos
Autor principal: Leiter, Lawrence A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7261305/
https://www.ncbi.nlm.nih.gov/pubmed/32323156
http://dx.doi.org/10.1007/s13300-020-00812-2